Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
VAIA N/A - protocol | — | R 82 943 | 63d | — | — | ~4 | ~R 168 736 indirect | — |
VAI Variant #02 | — | R 48 879 | 21d | — | — | ~3 | ~R 146 638 indirect | — |
VACA Variant #01 | — | R 33 324 | 21d | — | — | ~10 | ~R 173 122 indirect | — |
EVAIA Variant #01 | — | R 30 444 | 21d | — | — | ~4 | ~R 121 777 indirect | — |
Busulfan and Melphalan Variant #01 | — | R 5 951 | — | — | — | 1 | R 5 951 PFS proxy | 1 |
5 of 5 regimens shown